Physician profile
Cici Zhang
NPI 1528328077
$5,167.24
in general payments reported to CMS, 2019-2025
20 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.79 · 2020: $59.53 · 2021: $405 · 2022: $2,143 · 2023: $892 · 2024: $877 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,496.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,411.41 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $1,286.40 | 2021-2025 | Interstim |
| Thd America, INC. | $1,133.40 | 2021-2025 | |
| Davol INC. | $232.61 | 2025 | Surgiphor, Arista |
| Takeda Pharmaceuticals U.S.A., INC. | $210.12 | 2022-2025 | Gattex |
| Ethicon US, LLC | $159.99 | 2021-2025 | Harmonic |
| Baxter Healthcare | $136.68 | 2020-2024 | Seprafilm, Perclot, Tisseel |
| Dilon Technologies, INC. | $134.88 | 2025 | Hemoblast Bellows |
| Lexington Medical, INC. | $123.43 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Allergan, INC. | $106.05 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $62.45 | 2024-2025 | |
| Braintree Laboratories, INC. | $26.39 | 2025 | Sutab, Suflave |
| Innovation Technologies INC | $26.01 | 2025 | Irrisept |
| Smith+Nephew, INC. | $22.80 | 2020 | |
| La Jolla Pharmaceutical Company | $19.50 | 2023 | Xerava |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $19.14 | 2025 | |
| Hydrofera LLC | $16.75 | 2024 | Hydrofera Blue |
| Shire North American Group INC | $16.31 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.49 | 2019 | |
| Covidien LP | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cici Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.